Alzheimer’s and Parkinson’s Disease: a gut feeling that we’re looking in the wrong places

Laura Brown: Despite researchers’ best efforts, a definite cure has yet to be found for either Parkinson’s or Alzheimer’s disease. Over the last decade, the brain has been the focal point for the origin of these diseases, but scientists are now turning their attention to elsewhere


Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation

Ben Libberton, Postdoc and Public Information Officer, Karolinska Institute…researcher at the Swedish Medical Nanoscience Center in Stockholm. New research from Elisabeth Grice and Phillip Scott at the University of Pennsylvania has shown that dysbiosis in the skin of lab mice was transimissible and promoted higher levels of skin inflammation.


INDUSTRIAL PhD PROGRAM SUPPORTS MICROBIOTA RESEARCH

Three years ago, Taconic Biosciences and the University of Copenhagen came together to sponsor an Industrial PhD student through a program supported by Innovation Fund Denmark (IFD). IFD invests in new knowledge and technology creating growth and employment in Denmark.


How holobionts get sick—toward a unifying scheme of disease

Silvio D. Pitlik and Omry Koren: We hypothesize that probably every illness of holobionts is characterized by some perturbation of the microbiome/microbiota into a pathobiome.


The Florence Statement on Triclosan and Triclocarban

SUMMARY: The Florence Statement on Triclosan and Triclocarban documents a consensus of more than 200 scientists and medical professionals on the hazards of and lack of demonstrated benefit from common uses of triclosan and triclocarban.


The bug hunters and the microbiome

Trevor Lawley and Gordon Dougan are bug hunters, albeit not the conventional kind.


Science Journalist Ed Yong Gives a ‘Voice to the Voiceless,’ With Irreverence and Humor

Eric J. Topol, MD; Ed Yong, MPhil, DISCLOSURES : Eric J. Topol, MD: Hello. I am Eric Topol. I am editor-in-chief of Medscape. I am really privileged today to have Ed Yong with me,


Bipolar, Schizophrenia, and the Microbes Inside You

By Candida Fink, MD: Can the bacterial community that lives in your gut actually be related to psychiatric illnesses such as schizophrenia and bipolar disorder?


Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development

Nelly Amenyogbe, Tobias R. Kollmann and Rym Ben-Othman: Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system.


AN INDUSTRY GOES FOR THE GUT

Where is the microbiome-based therapeutics market headed? A Charles River Think Tank explores the possibilities for changing how we treat disease.


WEBINAR: Murine Lung in Microbiome Research

Thursday, June 8, 2023 at 11 a.m. ET/5 p.m. CET Presented by: Kenneth Klingenberg Barfod, cand.scient.bio, PhD at National Research Centre for the Working Environment


Why Should we be Excited about the Emerging Microbiome Field?

A panel of experts at Microbiome Invest in London discussed the unlimited applications of the microbiome and how emerging companies may have a big impact on healthcare.


Microbiome tests arrive on market but doubt abounds

The microbiome–the collection of bacteria that live in and on you–appears headed for the big time.


CD44 is it all about the Gut?

There is a real move to suggest that the influence of the immune system is because of bacteria in the gut. Every science meeting has a session on it.


Fecal Micobiota Transplantation to Treat Sepsis of Unclear Etiology*

Gaines, Sara MD; Alverdy, John C. MD: Critical Care Medicine, Editorials: Providing normal feces to the intestinal tract of a patient suffering from life-threatening infection dates back to the fourth century when the Chinese medical literature described treating food poisoning with fecal material known as “golden soup (1).”


The Microbiome and Human Obesity: Wait a Minute

In the pipeline: Derek Lowe’s commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine. For the last few years, it has been impossible to escape talk of the microbiome – the associated bacteria (and other organisms) that live in and on the human body.


RISE IN USAGE OF GERM-FREE MICE

From Meghan M. McBride, PhD: Germ-free mice are not new. Taconic Biosciences first started raising germ-free mice in 1960, after learning axenic husbandry techniques from the Laboratories of Bacteriology at the University of Notre Dame (LOBUND), where the first germ-free facility was established.


Creative Minds: The Human Gut Microbiome’s Top 100 Hits

Posted on May 18, 2023 by Dr. Francis Collins: Microbes that live in dirt often engage in their own deadly turf wars, producing a toxic mix of chemical compounds (also called “small molecules”) that can be a source of new antibiotics.


Microbiome Startup BiomX Raises $24 Million in Series A Round

CHICAGO (GenomeWeb) – BiomX, a startup focused on microbiome therapeutics via a proprietary microbiome modulation technology platform, said today that it has raised $24 million in Series A venture capital.


The Kavli Microbiome Ideas Challenge Funds Innovative, Cross-Cutting Research

Courtney Reyers: Washington, DC – May 8, 2023 – Three teams of researchers will be the recipients of the Kavli Microbiome Ideas Challenge that supports novel, cross-cutting tools and methods in the field of microbiome research.






Stay up-to-date!
Email Address *
First Name
Last Name

* indicates required



Terms & Conditions | Privacy Policy | © 2016 The Translational Microbiome Research Forum